Stryker Corporation (SYK) Receives Average Recommendation of “Hold” from Brokerages

Stryker Corporation (NYSE:SYK) has earned an average rating of “Hold” from the twenty-five ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $151.40.

Several equities research analysts recently weighed in on the company. SunTrust Banks, Inc. reissued a “buy” rating and set a $161.00 price objective on shares of Stryker Corporation in a report on Monday, October 2nd. Stifel Nicolaus raised their price objective on Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a report on Friday, July 28th. Oppenheimer Holdings, Inc. set a $156.00 price objective on Stryker Corporation and gave the company a “hold” rating in a report on Monday, October 30th. Canaccord Genuity raised their price objective on Stryker Corporation from $155.00 to $162.00 and gave the company a “buy” rating in a report on Friday, October 27th. Finally, BidaskClub lowered Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st.

ILLEGAL ACTIVITY WARNING: “Stryker Corporation (SYK) Receives Average Recommendation of “Hold” from Brokerages” was published by Markets Daily and is owned by of Markets Daily. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.themarketsdaily.com/2017/11/16/stryker-corporation-syk-receives-average-recommendation-of-hold-from-brokerages.html.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now directly owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 7.40% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Stryker Corporation by 2.8% during the 2nd quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after purchasing an additional 657,656 shares during the last quarter. BlackRock Inc. boosted its stake in Stryker Corporation by 5.2% during the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after purchasing an additional 1,139,082 shares during the last quarter. Geode Capital Management LLC boosted its stake in Stryker Corporation by 6.3% during the 1st quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock valued at $366,255,000 after purchasing an additional 166,133 shares during the last quarter. Jensen Investment Management Inc. boosted its stake in Stryker Corporation by 11.3% during the 3rd quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock valued at $351,141,000 after purchasing an additional 251,685 shares during the last quarter. Finally, Morgan Stanley boosted its stake in Stryker Corporation by 17.9% during the 1st quarter. Morgan Stanley now owns 2,144,472 shares of the medical technology company’s stock valued at $282,320,000 after purchasing an additional 325,661 shares during the last quarter. Institutional investors and hedge funds own 74.15% of the company’s stock.

Stryker Corporation (NYSE SYK) traded down $1.15 during midday trading on Thursday, hitting $154.80. The company had a trading volume of 701,100 shares, compared to its average volume of 1,179,359. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. Stryker Corporation has a 12 month low of $108.29 and a 12 month high of $160.62. The firm has a market cap of $58,560.00, a P/E ratio of 24.72, a price-to-earnings-growth ratio of 2.46 and a beta of 0.79.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The company had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter last year, the business posted $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. equities research analysts anticipate that Stryker Corporation will post 6.47 EPS for the current year.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Analyst Recommendations for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply